BioAge Labs, Inc. (BIOA)
9.86
-0.25
(-2.47%)
USD |
NASDAQ |
Aug 26, 10:41
BioAge Labs Total Assets (Quarterly) : 396.93M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 396.93M |
| March 31, 2026 | 397.65M |
| December 31, 2025 | 295.53M |
| September 30, 2025 | 305.09M |
| June 30, 2025 | 322.15M |
| March 31, 2025 | 343.84M |
| Date | Value |
|---|---|
| December 31, 2024 | 358.29M |
| September 30, 2024 | 337.38M |
| June 30, 2024 | 164.40M |
| March 31, 2024 | 179.60M |
| December 31, 2023 | 25.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 142.28B |
| Pfizer Inc. | 201.13B |
| Oramed Pharmaceuticals, Inc. | 369.64M |
| Liquidia Corp. | 521.92M |
| Neumora Therapeutics, Inc. | 125.25M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.02M |
| Shareholders Equity (Quarterly) | 374.91M |
| Debt to Equity Ratio | 0.0076 |
| Current Ratio | 17.19 |
| Net Debt Paydown Yield | 0.13% |